Related Experiment Videos
Azithromycin in an experimental Staphylococcus aureus abscess model
D M Bamberger1, B L Herndon, P R Suvarna
1Section of Infectious Diseases, University of Missouri-Kansas City School of Medicine 64108-2792, USA.
Abstract:
We studied the efficacy and pharmacokinetics of azithromycin in a rabbit tissue-cage Staphylococcus aureus abscess model. A dosage of 15 mg/kg/day azithromycin was administered to rabbits with 24 h or 2 week old infected tissue cages and to uninfected controls. Concentrations of azithromycin were higher in the infected compared with the uninfected tissue cages. Azithromycin was effective in reducing the bacterial concentrations in both groups of infected tissue cages by approximately 3 log10 cfu/mL compared with untreated controls after 8 days of therapy. Fifty percent of the 24 h and 29% of the 2 week infected tissue cages became culture-negative.
Insights
Azithromycin effectively reduced Staphylococcus aureus bacterial concentrations in rabbit abscess models. This antibiotic achieved significant bacterial reduction and culture-negativity in infected tissue cages.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Staphylococcus aureus abscesses pose significant treatment challenges.
- Understanding antibiotic efficacy in localized infections is crucial.
Purpose of the Study:
- To evaluate the efficacy and pharmacokinetics of azithromycin.
- To assess azithromycin's effectiveness in a rabbit Staphylococcus aureus abscess model.
Main Methods:
- Rabbits received 15 mg/kg/day azithromycin in infected (24h or 2-week old) and uninfected tissue cages.
- Azithromycin concentrations were measured in tissue cage fluid.
- Bacterial concentrations were quantified after 8 days of therapy.
Main Results:
- Azithromycin concentrations were higher in infected compared to uninfected tissue cages.
- A significant reduction of approximately 3 log10 cfu/mL in bacterial concentrations was observed in treated groups.
- 50% of 24h and 29% of 2-week infected cages became culture-negative.
Conclusions:
- Azithromycin demonstrates significant efficacy in reducing bacterial burden in a Staphylococcus aureus abscess model.
- The drug's pharmacokinetic profile supports its effectiveness in infected tissues.
- Azithromycin offers a potential therapeutic option for S. aureus abscesses.